| # | Drug | Count |
|---|---|---|
| 0 | ALTEPLASE | 441 |
| 1 | RIVAROXABAN | 286 |
| 2 | ASPIRIN | 204 |
| 3 | ASPIRIN 325 MG | 189 |
| 4 | ASPIRIN 81 MG | 189 |
| 5 | DABIGATRAN ETEXILATE | 144 |
| 6 | DABIGATRAN ETEXILATE MESYLATE | 141 |
| 7 | CLOPIDOGREL | 120 |
| 8 | CLOPIDOGREL BISULFATE | 108 |
| 9 | METOPROLOL TARTRATE | 76 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TENECTEPLASE | 61 | 0.0381 |
| 1 | ALTEPLASE | 441 | 0.0293 |
| 2 | IDARUCIZUMAB | 26 | 0.0181 |
| 3 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 4 | BIVALIRUDIN | 6 | 0.0060 |
| 5 | NICARDIPINE | 24 | 0.0054 |
| 6 | ISOPROTERENOL HYDROCHLORIDE | 2 | 0.0046 |
| 7 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 2 | 0.0045 |
| 8 | EDARAVONE | 7 | 0.0044 |
| 9 | ARGATROBAN | 5 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 340 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 233 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 214 |
| 3 | P2Y12 Platelet Inhibitor [EPC] | 96 |
| 4 | beta-Adrenergic Blocker [EPC] | 91 |
| 5 | Loop Diuretic [EPC] | 78 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 75 |
| 7 | Corticosteroid [EPC] | 67 |
| 8 | Proton Pump Inhibitor [EPC] | 59 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 57 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 26 | 0.0181 |
| 1 | Anti-coagulant [EPC] | 11 | 0.0030 |
| 2 | Osmotic Diuretic [EPC] | 11 | 0.0021 |
| 3 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 4 | Factor Xa Inhibitor [EPC] | 340 | 0.0012 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 96 | 0.0008 |
| 6 | Antifibrinolytic Agent [EPC] | 7 | 0.0007 |
| 7 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |
| 8 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 9 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |